Drug discovery companies identify, validate and develop new therapeutic candidates for the prevention and treatment of disease. The sector combines biology, chemistry, data science and clinical expertise to bring new medicines from concept to clinic.
This category includes companies working on:
Browse 422 UK drug discovery companies below.
ACE inhibitors for safer cardiovascular and fibrosis treatment
Angiodesign is a seed-stage drug discovery company developing next-generation domain-selective inhibitors of angiotensin-converting enzyme (ACE). Unlike current-generation ACE…
Pre-competitive biologics drug discovery platforms and services for partners
Alloy Therapeutics UK is the Cambridge-based research operation of Alloy Therapeutics, a biotechnology platform company providing pre-competitive drug discovery technologies and…
Chemistry-led CRO and CDMO for pharmaceutical and diagnostics R&D
High Force Research is an independent chemistry CRO and CDMO providing synthetic chemistry, process development, and GMP manufacturing services to the pharmaceutical, biotech, and…
Integrated academic drug discovery facility for anti-infectives and innovative targets
The Drug Discovery Unit is an academic drug discovery facility at the University of Dundee, integrating medicinal chemistry, high-throughput screening, structural biology, cell…
CBD-based licensed medicines for chronic inflammatory pain
Ananda Pharma is an AQSE-listed UK biotechnology company developing pharmaceutical-grade cannabidiol formulations as licensed medicines for chronic inflammatory pain conditions.…
Generative AI platform for whole-organism biological modelling
AI Vivo is an early-stage Cambridge biotechnology company developing a generative AI system that constructs multi-scale biological models linking molecular targets through tissue…
Therapeutic cancer vaccines based on recombinant overlapping peptide technology
Oxford Vacmedix is a clinical-stage biopharma company developing therapeutic cancer vaccines using its proprietary Recombinant Overlapping Peptide (ROP) platform. ROPs stimulate…
MicroRNA therapeutics for tendon and musculoskeletal disease
Causeway Therapeutics is a clinical-stage biotechnology company developing first-in-class microRNA therapies for musculoskeletal and age-related conditions. Its lead asset TenoMiR…
Precision calcium channel medicines for epilepsy and Parkinson's disease
Lario Therapeutics is developing first-in-class precision medicines as disease-modifying treatments for severe neurological disorders, including genetically defined epileptic…
Organ-on-a-chip systems for human-relevant preclinical drug testing
CN Bio is a UK biotechnology company developing organ-on-a-chip microphysiological systems for preclinical drug discovery and safety testing. Its platform recreates human organ…
Integrated chemistry and development CRO for small molecules
CatSci is a Cardiff-headquartered contract research organisation providing integrated chemistry, analytical, and development services to biotech and pharmaceutical companies.…
Global diabetes and cardiometabolic medicines leader
Novo Nordisk Limited is the UK commercial and medical affiliate of Novo Nordisk A/S, the Danish pharmaceutical company focused on diabetes, obesity, and cardiometabolic disease.…